We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mobile Device Rapidly Detects Zika and Related Viruses

By LabMedica International staff writers
Posted on 31 Mar 2017
A team of biologists and engineers have developed a smartphone-controlled, battery-operated, low-weight diagnostic technology that costs as little as USD 100 and can detect Zika, dengue, and chikungunya viruses within 30 minutes. More...
The same platform can also be adapted to detect other human or animal pathogens.

Accurate testing for these viruses currently requires a laboratory with expensive instruments, making local testing unrealistic for limited-resource clinics where the viruses are prevalent. The team, from Sandia National Laboratories (Livermore, CA, USA), used smartphone technology as a key feature: “In addition to creating an app that serves as a simple interface to operate the device, we were able to adapt smartphone camera sensors to replace traditional laboratory sample analysis tools, allowing for unprecedented mobility,” said lead author Aashish Priye.

The “laboratory in a box” device is based on the loop-mediated isothermal amplification (LAMP) diagnostic method, which eliminates PCR thermal cycling as well as the need to process the biological sample (e.g. blood or urine) before testing. LAMP copies viral DNA/RNA but without the heating/cooling cycles of PCR, so a heavy-duty power source is not needed. The addition of a few carefully designed biochemical reagents allows a LAMP box to test a sample that is heated only once for 30 minutes.

“We’ve demonstrated that the chemistry we’re using can amplify viral RNA directly from raw, unprocessed samples,” said project lead Robert Meagher, “That is the ideal for a point-of-care testing scenario because you don’t want to have extra equipment for isolating DNA or RNA.” Meagher and team previously developed a method to combine LAMP with an additional detection technique so that multiple viruses could be tested simultaneously. This other technique, named quenching of unincorporated amplification signal reporters (QUASR), involves using synthetic virus-based primers tagged with fluorophores for the sample-DNA/RNA amplification step.

For the Zika project, Meagher’s team developed a novel algorithm that allows a smartphone sensor to act as a fluorimeter, detecting QUASR LAMP light signals if they appear. The user need only place the smartphone on top of the LAMP box and open an app that turns on the heater to initiate the LAMP reaction, after which the smartphone photographs the sample. The app then employs a novel image analysis algorithm to determine the color and brightness of the fluorescence emitted from the LAMP reaction.

Zika, dengue, and chikungunya are spread via the same mosquito vector and have similar early symptoms. The team’s prototype diagnostic tool could enable care providers to test quickly for all three at the same time, preventing misdiagnoses.

The cost of making a LAMP box prototype to test for these viruses depends largely on the cost of the phone selected for using it with. “There are billions of smartphones in the world, even in developing countries, and this tool doesn’t require the highest-end smartphone on the market,” said Priye, “It only needs to have an optical sensor and be able to run the app.” The smartphone used in Sandia’s successful tests of the current prototype costs only USD 20.

The study, by Priye A et al, was published online March 20, 2017, in the journal Scientific Reports.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Electrolyte Analyzer
BKE-B
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.